Cellectricon has appointed Dr. Franziska Denk, Lecturer at the Wolfson Centre for Age-Related Diseases, King’s College London, to its scientific advisory board. Dr. Denk brings extensive expertise in e.g. neuroimmune interactions and epigenetic mechanisms in the context of chronic pain to the advisory board.

Dr. Denk studied Experimental Psychology at the University of Oxford and completed her DPhil there in 2009 studying alternative splicing of the tau protein in neurodegenerative disease. She started her own research group in 2017 with the help of an MRC New Investigator Research Grant. Since then, she has also received funding from the European Union (IMI2), industry and several charities. Her lab studies the peripheral nervous system and its involvement in chronic pain conditions by applying transgenic mouse models and high-throughput molecular analyses, such as RNA-seq and Cut&Tag-seq, on sorted cell populations. Dr. Denk is passionate about data sharing and interdisciplinary research in an open, positive research culture. She is also looking to promote these values with future generations of scientists, as Co-Director of a recently established Wellcome Trust PhD Training Scheme in Neuro-immune Interactions at King’s College London.

”Cellectricon have decided to broaden their preclinical research services to also explore inflammatory mechanisms and factors involved in the chronification of pain”, said Dr. Denk. “Neuroimmune interactions and interdisciplinary cross-talk are close to my heart”, she added. “I am therefore keen to support Cellectricon’s efforts to develop novel in vitro models in this space and am delighted to join their Advisory Board.”

“We are glad to welcome Franziska to our Scientific Advisory Board, where she will bring extensive disease area knowledge and be a key contributor in further enhancing Cellectricon’s chronic pain research and beyond”, said Cellectricon’s CSO, Dr. Paul Karila.